Bristol Myers Squibb Announces Progress Toward Long-Term Inclusion & Diversity Goals and Health Equity Commitments Pharmaceutical Investing
Boosh Announces the Closing of its Private Placement Offering and Opens Listing Issuer Exemption Offering Life Science Investing
Reneo Pharmaceuticals Achieves Target Enrollment in the Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies Genetics Investing
Astellas Announces Phase 3 China ARCHES Study of XTANDI® Meets Primary Endpoint Life Science Investing
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Qualtrics , Seagen Inc. , Provention Bio Inc. , Kimball International, Inc. Life Science Investing
AbbVie Showcases Strength of Dermatology Portfolio with New Data Presented at the 2023 AAD Annual Meeting Pharmaceutical Investing
BetterLife Files Amended and Restated Offering Document for Offering of Units Pharmaceutical Investing
